Definition of Disease-Risk Stratification Groups in Childhood Medulloblastoma Using Combined Clinical, Pathologic, and Molecular Variables
- 10 April 2011
- journal article
- research article
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 29 (11) , 1400-1407
- https://doi.org/10.1200/jco.2010.30.2810
Abstract
Purpose Medulloblastomas are heterogeneous and include relatively good-prognosis tumors characterized by Wnt pathway activation, as well as those that cannot be successfully treated with convention...Keywords
This publication has 24 references indexed in Scilit:
- Treatment of early childhood medulloblastoma by postoperative chemotherapy and deferred radiotherapyNeuro-Oncology, 2009
- Outcome Prediction in Pediatric Medulloblastoma Based on DNA Copy-Number Aberrations of Chromosomes 6q and 17q and the MYC and MYCN LociJournal of Clinical Oncology, 2009
- Beta‐catenin status in paediatric medulloblastomas: correlation of immunohistochemical expression with mutational status, genetic profiles, and clinical characteristicsThe Journal of Pathology, 2009
- Medulloblastoma: new insights into biology and treatmentArchives of Disease in Childhood: Education & Practice, 2008
- Integrated Genomics Identifies Five Medulloblastoma Subtypes with Distinct Genetic Profiles, Pathway Signatures and Clinicopathological FeaturesPLOS ONE, 2008
- The Origins of Medulloblastoma SubtypesAnnual Review Of Pathology-Mechanisms Of Disease, 2008
- Wnt/Wingless Pathway Activation and Chromosome 6 Loss Characterise a Distinct Molecular Sub-Group of Medulloblastomas Associated with a Favourable PrognosisCell Cycle, 2006
- Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trialPublished by Elsevier ,2006
- Genomics Identifies Medulloblastoma Subgroups That Are Enriched for Specific Genetic AlterationsJournal of Clinical Oncology, 2006
- c-Myc Overexpression Causes Anaplasia in MedulloblastomaCancer Research, 2006